257 related articles for article (PubMed ID: 34360607)
1. Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD.
Wang CH; Liu HM; Chang ZY; Huang TH; Lee TY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360607
[TBL] [Abstract][Full Text] [Related]
2. Losartan Attenuates Insulin Resistance and Regulates Browning Phenomenon of White Adipose Tissue in
Liu HM; Wang CH; Chang ZY; Huang TH; Lee TY
Curr Issues Mol Biol; 2021 Oct; 43(3):1828-1843. PubMed ID: 34889901
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.
Yang YY; Lee PC; Huang YT; Lee WP; Kuo YJ; Lee KC; Hsieh YC; Lee TY; Lin HC
Clin Sci (Lond); 2014 Jan; 126(2):163-74. PubMed ID: 23875703
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation.
Liu Y; Ma Z; Zhao C; Wang Y; Wu G; Xiao J; McClain CJ; Li X; Feng W
Toxicol Lett; 2014 Apr; 226(2):117-23. PubMed ID: 24503013
[TBL] [Abstract][Full Text] [Related]
6. HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver.
Arai T; Tanaka M; Goda N
Sci Rep; 2018 Sep; 8(1):14230. PubMed ID: 30242180
[TBL] [Abstract][Full Text] [Related]
7. High-fat diet overfeeding promotes nondetrimental liver steatosis in female mice.
Arisqueta L; Navarro-Imaz H; Labiano I; Rueda Y; Fresnedo O
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G772-G780. PubMed ID: 30095299
[TBL] [Abstract][Full Text] [Related]
8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
9. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation.
Zhao P; Han SN; Arumugam S; Yousaf MN; Qin Y; Jiang JX; Torok NJ; Chen Y; Mankash MS; Liu J; Li J; Iwakiri Y; Ouyang X
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G387-G397. PubMed ID: 31411894
[TBL] [Abstract][Full Text] [Related]
10. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
11. IL-25 protects against high-fat diet-induced hepatic steatosis in mice by inducing IL-25 and M2a macrophage production.
Zheng XL; Wu JP; Gong Y; Hong JB; Xiao HY; Zhong JW; Xie B; Li BM; Guo GH; Zhu X; Wang AJ
Immunol Cell Biol; 2019 Feb; 97(2):165-177. PubMed ID: 30242904
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease.
Mesarwi OA; Shin MK; Bevans-Fonti S; Schlesinger C; Shaw J; Polotsky VY
PLoS One; 2016; 11(12):e0168572. PubMed ID: 28030556
[TBL] [Abstract][Full Text] [Related]
13. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
Nath B; Levin I; Csak T; Petrasek J; Mueller C; Kodys K; Catalano D; Mandrekar P; Szabo G
Hepatology; 2011 May; 53(5):1526-37. PubMed ID: 21520168
[TBL] [Abstract][Full Text] [Related]
15. Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1α.
Cui Y; Guo C; Xia Z; Xue Y; Song B; Hu W; He X; Liang S; Wei Y; Zhang C; Wang H; Xu D; Zhang S; Fang J
Acta Biomater; 2023 Oct; 169():500-516. PubMed ID: 37574157
[TBL] [Abstract][Full Text] [Related]
16. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
[TBL] [Abstract][Full Text] [Related]
17. [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats].
Shen WD; Zhang W; Xu QH; Liu PF
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):749-754. PubMed ID: 27938560
[No Abstract] [Full Text] [Related]
18. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte HIF-1 and Intermittent Hypoxia Independently Impact Liver Fibrosis in Murine Nonalcoholic Fatty Liver Disease.
Mesarwi OA; Moya EA; Zhen X; Gautane M; Zhao H; Wegbrans Giró P; Alshebli M; McCarley KE; Breen EC; Malhotra A
Am J Respir Cell Mol Biol; 2021 Oct; 65(4):390-402. PubMed ID: 34003729
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice.
Chen YS; Liu HM; Lee TY
Cells; 2019 Mar; 8(3):. PubMed ID: 30884843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
